Menthe E. Bergmans
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial.
Journal: Journal of the American Academy of Dermatology
Published: February 24, 2026
S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitis.
Journal: British journal of clinical pharmacology
Published: November 07, 2025
Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trial.
Journal: British journal of clinical pharmacology
Published: July 25, 2025
Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumab.
Journal: British journal of clinical pharmacology
Published: April 15, 2025
Lesional Psoriasis is Associated With Alterations in the Stratum Corneum Ceramide Profile and Concomitant Decreases in Barrier Function.
Journal: Experimental dermatology
Published: May 22, 2024
Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial.
Journal: Journal of lipid research
Published: April 24, 2024
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
Journal: Journal of the American Academy of Dermatology
Published: August 22, 2023
Intradermal substance P as a challenge agent in healthy individuals.
Journal: Clinical and translational science
Published: February 23, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026